were used to verify the cytopathological effects of TMT. Accompanying changes in 2 synaptic vesicleassociated proteins, synapsin I and ~38, and the astrocyteassociated protein, glial fibrillary acidic protein (GFAP), were measured by radioimmunoassay (RIA). Immunohistochemistry of GFAP and incorporation of 3H-thymidine into GFAPpositive astrocytes also were used to characterize astrocytic responses to TMT-induced injury. Finally, quantitative P-dimensional PAGE was employed to detect additional proteins affected by TMT. Acute administration of TMT caused large dose-and time-dependent decreases in synapsin I and p38 in hippocampus; the same proteins were largely unaffected in a nonlimbic structure, the frontal cortex. Twelve weeks after dosing, the concentrations of synapsin I and p38 and, to a lesser extent, the absolute amount of these proteins in hippocampus had returned to near control values, findings that are suggestive of reactive synaptogenesis. TMT caused large dose-and time-dependent increases in GFAP that were not confined to hippocampus. Twelve weeks after dosing, the amounts of GFAP in hippocampus and frontal cortex had returned to near control values, findings indicative of a transient astrocytic response to brain injury. lmmunohistochemistry of GFAP revealed widespread astrocytic reactivity as a consequence of exposure to TMT, a response that resulted in part from the proliferation of astrocytes. Additional neurotypic proteins altered by TMTinduced injury included one of the neurofilament (NF) triplet proteins (~88) and a protein with the electrophoretic characteristics of neuron-specific enolase (NSE). The data indicate that measurements of neurotypic and gliotypic proteins may be used to characterize the temporal and regional patterns of neuronal and glial responses to injury.
Chemical-induced injury to the mammalian CNS is often manifested by alterations in the cytoarchitecture of specific neuroanatomical regions. Within the affected area, the response to chemical insult may encompass several types of neurons and glia (Price and Griffin, 1980; Spencer and Schaumberg, 1980) . Because proteins that distinguish the diverse cell types comprising the mammalian nervous system have been described (Raff et al., 1979; Schachner, 1982; Milner and Sutcliffe, 1983; De Blas et al., 1984; we proposed that measurements of these nervous system-specific proteins could be used to detect and characterize the cellular responses to chemical-induced injury (O'Callaghan and Miller, 1983) . In support of this hypothesis, we have demonstrated that the cytopathological changes caused by several known neurotoxicants are accompanied by quantitative changes in proteins associated with the affected cell types (O'Callaghan et al., 1983; Miller and O'Callaghan, 1984; O'Callaghan and Miller, 1984 , 1985 . One neurotoxic chemical employed in our previous studies was trimethyltin (TMT) , an organometallic compound that preferentially destroys limbic system neurons (Brown et al., 1979; Bouldin et al., 198 1; Chang and Dyer, 1983) . By using TMT as a denervation tool to alter the morphology of a limbic structure, the hippocampus, we were able to demonstrate accompanying changes in neuron-specific phosphoproteins . On the basis of both radioenzymatic assays and radioimmunoassays (RIAs), we found that acute administration of TMT to the rat resulted in large, dose-related decreases in hippocampal synapsin I, a synapse-specific, synaptic vesicleassociated phosphoprotein (De Camilli et al., 1983a , b, Huttner et al., 1983 Navone et al., 1984; . Consistent with the region-selective effects of TMT, decrements in synapsin I were not observed in the frontal cortex. These data suggested that measurements of nervous system-specific proteins could be used to characterize and quantify region-selective and cell typespecific responses to CNS injury.
The objective of the present study was to characterize the time-and dose-dependent changes in both neuron-specific (neurotypic) and glia-specific (gliotypic) proteins as a consequence of chemical-induced injury of the CNS. Following the administration of TMT, the synaptic protein synapsin I and another synaptic vesicle-localized protein, ~38 (Jahn et al., 1985; Wiedenmann and Franke, 1985) , as well as the astroglia-localized protein, glial fibrillary acidic protein (GFAP) (Bignami et al., 1972 (Bignami et al., , 1980 Eng, 1980 Eng, , 1985 , were quantified by RIA. Immunohistochemistry of GFAP was employed to evaluate patterns of astrocytic response to injury. Finally, quantitative 2-dimensional PAGE was used to identify additional neurotypic and gliotypic proteins affected as a consequence of the administration of TMT. Our results demonstrated that measurements of neurotypic and gliotypic proteins could be used to characterize the temporal and regional patterns of neuronal and glial response to chemical-induced injury of the CNS. A preliminary report of portions of this investigation has previously appeared (Viana et al., 1985) .
Materials and Methods
Materials. Bolton-Hunter reagent, 1Z51-protein A (2-10 &i/pg; 1 Ci = 37 GBq) and 3H-thymidine (6.7 Ci/mm; 1 Ci = 37 GBq) were purchased from New EnglandNuclear (Boston, MA). Synapsin I&d corr&ponding antisera were the gifts of Drs. Jesse Chan and Eva Perdahl (Rockefeller University). Mon&lonal antibodies to p38 (~7.1, ~7.2, ani ~7.3) were the gift of Dr. Reinhard Jahn (Rockefeller University). Antiserum to GFAP. GFAP immunohistochemistrv kits. and rabbit anti-mouse IgG were from Dako (Santa Barbara, CA\. Monoclonal antineurofilam&t protein (~68) was from Boehringer Mannheim Biochemicals (Indianapolis, IN). Nitrocellulose paper (0.2 PM pore size, of German manufacture) was purchased from Schleicher and Schuell (Keene, NH). Other reagents and materials used in the RIAs were from the reported sources (Goelz et al., 1981; Nairn et al., 1982; Jahn et al., 1984) . All reagents for 2dimensional PAGE were purchased from Bio-Rad Laboratories (Richmond, CA), with the following exceptions: Tris and dithiothreitol were from Calbiochem (San Diego, CA), Nonidet P-40 was obtained from Particle Data Labs (Elmhurst, IL), and ampholines, pH 3.5-10, were from LKB (Gaithersburg, MD). Ovalbumin, BSA, and molecular weight standards were purchased from Sigma Chemical Company (St. Louis, MO). Nuclear track emulsion (NTB-2) and XRP x-ray film were obtained' from Kodak (Rochester, NY). TMT hydroxide was purchased from ICN Pharmaceuticals (Plainview, NY). All other reagents were of the highest analytical grade and were obtained from various commercial sources.
Subjects. Male Long-Evans rats (200-250 gm), purchased from Charles River Breeding Laboratories (Wilmington, MA), were housed individually in a temperature (22°C ? 2)-and humidity (50 + lo%)-controlled colony room maintained on a 12 hr light : 12 hr dark cycle beginning at 0600. Food (Purina Rat Chow) and water were continuously available. The animals were administered TMT or its vehicle (0.9% saline) by injection into a lateral tail vein; dosages of TMT are expressed as the free base and were administered in a volume of 1 .O ml/kg body weight. Dose-effect determinations (0.0-9.0 mg/kg TMT) were made 21 d postdosing. Time-effect determinations were made after the administration of saline or 8.0 mg/kg TMT. All subjects were killed by decapitation.
Brain dissection and tissue preparation. Immediately after decapitation, whole brains were removed from the skull and then bisected in the midsagittal plane. The left hemibrains were prepared for histological examination (see below) and the right hemibrains were prepared for biochemical measurements according to the following procedures: the hippocampus was removed by free-hand dissection and the frontal cortex was obtained by coronal section (free-hand) at the level of the anterior commissure (bregma, 2.7 mm; see Paxinos and Watson, 1982) . Care was taken not to include olfactory nuclei or olfactory cortex with samples of frontal cortex. The dissected brain regions were weighed, homogenized by sonification (Kontes cell disrupter) in 10 volumes of hot (9&95OC) SDS and then frozen at -70°C for subsequent analysis bv RIA and 2-dimensional PAGE (see below). In one ofthe exneriments. sibfields of dorsal hippocampus were dissected, as previousl; described . In brief, five IOO-PM-thick serial transverse sections were prepared with a McIlwain tissue chopper (Brinkman Instruments, Westbury, NY). With the aid of a dissecting microscope, individual slices were divided into areas approximating Ck 1, CA3, aid fascia dentata usine. a modification (O'Callaphan and Miller. 1984 . and see legend to Table 2 ) of the procedure of Danscher et al. (1976) : The samples from a given region were then pooled, sonified in 75 ~1 of hot SDS, and stored at -70°C before RIA.
Histology. The left hemibrains were immersion-fixed in 10% neutralbuffered Formalin immediately after removal from the skull. The tissue was embedded in paraffin and sectioned in the sagittal plane, beginning at the midline. Two sequential sections were cut at thicknesses of 10 and 6 PM every 100 PM; the 10 PM sections were stained with cresyl violet and the 6 FM sections were prepared for immunohistochemistry and autoradiography (see below). With the aid of a 1 PM ocular grid, estimations of hippocampal pyramidal cell loss were made by counting the number of cells (CA l-CA4) with an intact nucleus and a prominent nucleolus. Counts were obtained every third section (300 PM distance) throughout the hippocampal formation. The nomenclature of Lorente de N6 ( 1934) was used to describe anatomical subdivisions of the hippocampal formation.
RIA of synapsin I. Synapsin I was measured by detergent-based RIA according to the procedure of Goelz et al. (198 1) . Samples were normalized in 1% SDS to a protein concentration of 5 mg/ml before undergoing 1:50 dilution in RIA buffer (Goelz et al., 1981) . Samples, including standards, were assayed in quadruplicate using the microtiter plate system as described by Naim et al. (1982) .
RIA ofp38. Quantification of p38 was achieved by a modification of the dot-immunobinding procedure of Jahn et al. (1984) . In our procedure, samples were applied to the nitrocellulose sheets, using a slot-blot apparatus (Minifold II; Schleicher and Schuell) as a template. This modification resulted in faster sample application, greater reproducibility, and a greater sample capacity per cm* of nitrocellulose than the original procedure (see Jahn et al., 1984) . Samples containing 8.75 pg protein in 20 ~1 sample buffer were loaded into each well. Incubation of the nitrocellulose sheets with a mixture of monoclonal antibodies against ~38 (1:2000 each) was followed by washing in Tris-buffered saline and additional incubation in blocking solution for 30 min (see Jahn et al., 1984 ). This step was followed by incubation in rabbit antimouse IgG ( 1: 500) for 1 hr, with subsequent washing and blocking before incubation in lz51-protein A. The specificity and linearity of the ~38 assay have been described (Jahn et al., 1984 (Jahn et al., , 1985 .
RIA of GFAP. GFAP was assayed by the dot-immunobinding procedure of Jahn et al. (1984) as previously described (O'Callaghan and Miller, 1985) , with the exception that the technique for sample application was modified as described above for ~38. Each sample contained 3.75 Mug protein in 20 ~1 sample buffer. Antiserum to GFAP was used at a dilution of 1:500; the specificity of the GFAP antiserum and the linearitv of the assav have been described (O'Callaehan and Miller. 1985) . -Expression of RIA data. For assays of synapsin I, ~38, and GFAP, standard curves were constructed from dilutions of a single control sample. By comparing the immunoreactivity of each sample (saline and TMT) with that of the sample used to construct the standard curve, the relative specific activity (RSA) of each sample was obtained (e.g., see Miller, 1984, 1985) . The RSA of an individual sample (saline and TMT) was then multiplied by a constant that resulted in a mean RSA of 1.0 (100%) for the saline arouns soecified in the legends to Figures 3-6 and- Table 2 . Data are expressed on the basis of both the total (per tissue) and concentration (per milligram tissue protein). RSA values for total (synapsin I, ~38, or GFAP) reflect the amount of the protein assayed per hippocampus or frontal cortex, whereas RSA values for concentration (synapsin I, ~38, or GFAP) reflect the amount of the protein assayed per milligram of hippocampus or frontal cortex protein. Thus, changes in the RSA total would be indicative of changes in the absolute amount of a given protein, whereas changes in the RSA concentration would indicate alterations in the relative abundance of a given protein.
Protein assay. Total protein was determined by the method of Lowry et al. (195 1) using BSA as the standard.
Zmmunohistochemistry and microautoradiography. Sections (6 PM) obtained from the left hemibrain were deparaffinized, incubated in 0.1% trypsin for 15 min, and immunostained for GFAP according to the indirect immunoperoxidase method of Stemberger et al. (1970) ; the chromogen was aminoethylcarbazole. In some cases slides were counterstained with Mayer's hematoxylin. The anti-GFAP used for immunohistochemistry was the same as that employed in the RIA. Control slides, prepared by omitting the primary antiserum or by using nonimmune rabbit serum, demonstrated that the staining for GFAP was specific.
For autoradiography, subjects that had received saline or TMT (8 mg/kg) 1, 2, 3,4, or 5 d earlier were given an intraventricular injection of 3H-thymidine (20 &i in 20 ~1 of water) as described and killed 1 hr later. Brains were removed and processed for immunohistochemistry of GFAP, as described above. The slides then were dipped in NTB-2 emulsion diluted 1: 1 with 0.1% SDS and developed 1 week later by the method of Kopriwa and Leblond (1962) . The number of GFAP-positive cells (astrocytes), and the number of GFAP-positive cells with reduced silver halide grains over their nuclei were determined in the CA3c-CA4 regions of hippocampus. A cell was counted as an astroycte if it had an intact nucleus with positive staining for GFAP in the perikaryon or the cytoplasmic processes. Counts were obtained from sections taken every 300 WM throughout the extent of the hippocampal formation.
Two-dimensional gel electrophoresis and densitometry. Samples of hippocampus and frontal cortex (150 pg homogenate protein) were subjected to 2-dimensional PAGE according to the procedure of O'Farrell (1975) , except that the concentration of acrylamide in the second dimension was 10%. After electrophoresis, gels were stained with Coomassie blue R-250 and dried between sheets of dialysis membrane using heat and reduced pressure. To identify the spots corresponding to GFAP and NF ~68, samples were subjected to 2-dimensional PAGE and were transferred electronhoreticallv (Towbin et al.. 1979: Bumette. 198 1) onto sheets of nitrocellulose.-One sheet was assayed'for GFAP as de: scribed above and another sheet was assayed for neurofilament (NF) ~68 according to the double-antibody procedure described above for ~38. Using autoradiography to localize radioactivity bound to each transfer, it was revealed that the antibodies to GFAP and NF ~68 were localized at positions corresponding to the electrophoretic mobility of GFAP and NF ~68, respectively (data not shown). Serum albumin, actin, and (Y-and /3-tubulin were identified on the basis of corn&ration with the pure proteins (see Brock and McIlwain, 1985) . To quantify specific proteins, the stained gels were scanned with a computer-assisted, television-based image analyzer (Darwin Instruments, Winston-Salem, NC, see Telewski et al., 1983 , for a description). The integrated optical density (IOD) for selected proteins was determined after subtraction of background values. The IOD for each protein spot was divided by the IOD of ovalbumin that had been added to each sample before electrophoresis to control for gel-to-gel differences with respect to the degree of staining or the amount of protein that entered each gel (Sinicropi and McIlwain, 1983) . The IOD values for all proteins subjected to densitometry were shown to be linearly related to the amounts of protein applied to the gels over the range of densities observed for each protein.
Statistical analysis. The Statistical Analysis System (SAS; 1982) was used for data analyses. Treatment effects were analyzed by the t statistic or by analysis of variance (ANOVA). Duncan's Multiple Range Test was used to make group comparisons following a significant ANOVA. When group variances were unequal, comparisons were made by T, an approximate t statistic with Satterthwaite's approximation for the degrees of freedom (1946) .
Results
Brain weights. Acute administration of TMT caused dose-and time-dependent decreases in hippocampal weight without affecting the weight of frontal cortex. Time-course data for the effects of 8.0 mg/kg of TMT are shown in Table 1 . Twenty-one days after administration of TMT, hippocampal weight was reduced by 20%, an effect that was still evident 9 weeks later.
Histology. TMT (8 mg/kg) caused the characteristic destruction of hippocampal pyramidal cells with sparing of granule neurons (Fig. 1) . Areas CA3-CA4 appeared to be the most affected; however, neuron loss was noted throughout the pyramidal cell layer in all sections examined. Consistent with our previous findings , the acute administration of TMT was not associated with qualitative changes in the morphology of the frontal cortex, a nonlimbic region (Fig. 1) . Time-course data for the effects of TMT on pyramidal cell number are presented in Figure 2 . Twenty-one days after the administration of TMT, the number of pyramidal cell neurons had declined to 25% of control values; no further reductions in pyramidal cell number were observed by 84 d postdosing.
RIA of synapsin Z andp38 in hippocampus andfrontal cortex. The changes in hippocampal morphology 21 d after administration of TMT were associated with dose-related decreases in the synaptic vesicle-associated proteins synapsin I and ~38 ( 3). These effects of TMT were evident whether the data were expressed on a total (per hippocampus) or concentration (per milligram hippocampus protein) basis. In order to determine whether values for synapsin I and ~38 would reflect the regional specificity ofTMT-induced injury, the amounts ofthese proteins in frontal cortex were determined. In agreement with our previous observations , TMT did not affect values for synapsin I in frontal cortex. At the highest dosage tested, however, TMT caused large (40-45%) decrements in ~38 (total and concentration). The time course for the effects of TMT (8 mg/kg) on synapsin I and ~38 is shown in Figure 4 . No significant changes in hippocampal synapsin I and ~38 were observed 1, 2, 3, or 5 d following exposure to TMT. Seven days after administration of TMT, values (total and concentration) for hippocampal synapsin I and ~38 began to decline; maximal reductions were reached 35 dafter dosing. Values for total hippocampal synapsin I and ~38 increased slightly between 35 and 84 d postdosing but still remained well below corresponding control values. During this period, the concentration of synapsin I and ~38 returned to near control values. The RSA (total and concentration) for synapsin I and ~38 in frontal cortex did not differ significantly within the 12 week time course of the experiment.
RZA of GFAP in hippocampus and frontal cortex. In contrast to the results obtained for synapsin I and ~38, there were large dose-related increases in GFAP (total and concentration) associated with TMT-induced injury that were not restricted to the hippocampus (Fig. 5) . Twenty-one days after administration of TMT, values for GFAP in the hippocampus were increased by as much as 300 and 500% when expressed on a total and concentration basis, respectively. In frontal cortex, the corresponding increases in GFAP were not as large in magnitude as those in hippocampus; however, because control (0 mg/kg) values for GFAP in frontal cortex were roughly half those of hippocampus, the increases in frontal cortex GFAP, expressed as a percentage of control (0 mg/kg; frontal cortex), were nearly comparable to the corresponding increases observed in hippocampus. The time course of the effects of TMT (8.0 mg/kg) on GFAP is shown in Figure 6 . The temporal relationship of the TMTinduced increases in GFAP (hippocampus and frontal cortex) was similar to that of the decreases observed for synapsin I and ~38 (hippocampus): significant increases were not observed until 7 d postdosing, maximal effects were observed at day 35, and values had returned to near control levels by day 84.
RIA ofp38 and GFAP in regions of dorsal hippocampus. Slices of hippocampus were dissected into areas roughly approximating the major neuronal subfields to determine the intrahippocampal distribution of ~38 and GFAP and the extent to which each protein was altered by TMT in a given area ( Table 2) . The values for ~38 were uniformly distributed among hippocampal subfields, a finding consistent with our previous observation that the concentration of synapsin I did not vary among regions of the hippocampus . Furthermore, as with its effects on synapsin I , TMT caused decreases in the content (total and concentration) of ~38 in all regions of the hippocampal formation. Unlike the case with synapsin I and ~38, the distribution of GFAP within the hippocampus was uneven. Values for GFAP in fascia dentata (which includes CA3c, CA4, and fascia dentata; see Table 2 ) were nearly double those of area CA1 and were more than 8 times greater than those of CA3. The effect of TMT on GFAP also varied with respect to hippocampal areas; for example, 13-, 15-, and 67-fold increases in concentration were observed in fascia dentata, CAl, and CA3, respectively. Zmmunohistochemistry of GFAP. The increased concentration of GFAP in all regions of the hippocampus and in frontal cortex was suggestive of a widespread astrocytic response to TMT-induced injury. To explore this possibility, we used the antisera employed in the RIA to localize GFAP by immunocytochemistry. Representative light micrographs of tissue obtained from saline-and TMT-treated rats are shown in Figure  7 . Although several investigators (Bignami and Dahl, 1976; Eng and De Armond, 1982; Barrett et al., 1984; Mathewson and Berry, 1985) have reported that GFAP immunoreactivity is weak throughout the CNS of animals that have not undergone nervous system trauma, we found that GFAP immunoreactivity delineated stellate-shaped astrocytes in hippocampus (Fig. 7 , A, C) and frontal cortex (Fig. 7E ) of control subjects. GFAP immunoreactivity was distributed throughout all areas of the hippocampal formation (Fig. 7A) and was intense in the astrocytic processes, less so in the perikaryon, and absent in nuclei (Fig.  7C) . Twenty-one days after exposure to TMT (8.0 mg/kg), GFAP immunoreactivity had increased in all cell layers of the hippocampus (Fig. 7B) ; astrocytes proximal to neurons in CAl, CA3, and CA4 appeared to be most intensely immunoreactive. In comparison to immunoreactive astrocytes present in hippocampus from saline-treated rats (Fig. 7C ), those present in hippocampus from TMT-treated rats were characterized by markedly hypertrophied perikarya and processes (Fig. 70) . Increased immunoreactivity associated with swollen astrocytes was also seen in frontal cortex 3 weeks after administration of TMT (Fig. 70 . By day 84 after exposure to TMT, astrocytic reactivity had decreased in hippocampus and frontal cortex (data not shown).
The number of GFAP-positive cells appeared to increase at several sites within the hippocampus as a consequence of TMTinduced injury. To verify that astrocyte mitosis had occurred, rats were pulsed with 3H-thymidine. Maximal incorporation of label was observed 4-5 d after administration of TMT. Astro- 0 Slices of dorsal hippocampus were subdivided into areas designated fascia dentata, CAl, and CA3, as described . When dissected in this manner, regions designated CA 1 and CA3 would each contain a portion of CA2; subfields CA3c and CA4, as well as the molecular and granular layer of the dentate gyrus, would comprise the region designated fascia dentata. b Subjects were killed 21 d after the administration of saline (0.9%) or TMT (8.0 mg/kg). c Each value (n = 6) represents the mean RSA f SEM expressed on a total (per hippocampus) or concentration (per mg protein) basis. Values obtained for fascia dentata-saline were used to calculate a mean RSA = 1.00; see Materials and Methods for additional details.
* Significantly different from saline, p < 0.005. ** Significantly different from saline, p < 0.0005. *** Significantly different from saline, p < 0.000 1. were altered by TMT, we subjected homogenates of hippocampus and frontal cortex to 2-dimensional PAGE. Representative electrophoretic profiles are shown in Figure 9 . Proteins relatively low in abundance (e.g., synapsin I and ~38) or outside the limits of the pH gradient (e.g., synapsin I) were not detected. Of the total number of hippocampus and frontal cortex proteins resolved, only a small percentage showed qualitative changes in staining intensity as a consequence of the administration of TMT. As was expected from the RIA data, 1 protein that was consistently increased in hippocampus and frontal cortex was identified by immunoblotting as GFAP. Two other proteins, however, were consistently decreased in samples of hippocampus and frontal cortex. One of these was positively identified as the neuronal cytoskeletal protein NF p68 (Hoffman and Lasek, 1975) whereas the other (designated "NSE?") was tentatively identifed as NSE (Pickel et al., 1976; Schmechel et al., 1978) on the basis of its reported electrophoretic profile (Lim et al., 1983; Heydorn et al., 1985) . Computer-assisted densitometry revealed that TMT caused a significant reduction in both NF p68 and NSE in hippocampus, as well as the expected increase in GFAP (>4-fold) in hippocampus and frontal cortex (Table  3) .
Discussion
A single administration of TMT to the rat produces consistent regional and cell type-specific damage of the CNS (Brown et al., 1979; Chang and Dyer, 1983; O'Callaghan and Miller, 1984) . Our results demonstrate that these cytopathological effects of TMT are accompanied by time-and dose-dependent changes in neurotypic and gliotypic proteins. Together with our previous observations (O 'Callaghan and Miller, 1984 , 1985 , these data suggest that neurotypic and gliotypic proteins can be used to characterize the temporal and regional patterns of neuronal and glial responses to CNS damage. In agreement with our previous findings (O 'Callaghan and Miller, 1984) , TMT-induced damage of the hippocampus was manifested morphologically by decrements in wet weight and loss of pyramidal cells. On a per hippocampus (total) basis, these effects were accompanied by a permanent decrease in the synaptic vesicle-associated proteins synapsin I and ~38. This reduction in total synapsin I and p38 did not reflect a generalized decrease coincident with the loss of tissue, because the percentage decrease in these proteins was always greater than the percentage decrease in hippocampal weight. This observation indicates that a preferential loss of these proteins occurs as a direct or indirect consequence of TMT-induced damage to the hippocampus. Furthermore, because synapsin I and p38 are present in all nerve terminals (De Camilli et al., 1983a, b; Navone et al., 1986) , a reduction in the absolute amount of these proteins (total) is suggestive of a loss of synapses due to damage The concentration of synapsin I and p38 in hippocampus was also reduced in a dose-and time-dependent fashion following the administration of TMT. Unlike alterations in total synapsin (see Goelz et al., 198 1) . I and ~38, which reflect absolute changes, alterations in the concentration of these proteins, in theory, may result from increases in the content of other proteins, especially relatively abundant ones (e.g., cy-and P-tubulin, GFAP). Alternatively, changes in the concentration of synapsin I and p38 may reflect specific protein alterations that accompany injury to the hippocampus-an interpretation we favor because of the following observations. First, quantitative analysis of specific protein concentration by l- and f-dimensional PAGE, as well as by specific RIAs not reported here (e.g., cr-and P-tubulin; J. P. O'Callaghan, unpublished observations), failed to reveal changes in most proteins as a consequence of exposure to TMT, a finding that suggests that the changes in specific protein concentrations (synapsin I, ~38, GFAP, NF 68, and neuron-specific enolase, NSE) did not result from changes in the relative. abundance of other hippocampal proteins. 'Second, consistent with our findings, alterations in the concentration of specific brain proteins relevant to disease- (Marotta et al., 1981; Selkoe et al., 1982), trauma-{Soifer et al., 198 1; Perry et al., 1985) or stress- (Greenberg and Lasek, 1985) induced events occurred independently of changes in other tissue proteins. Finally, changes in the concentration of GFAP in frontal On the basis of our data, we cannot localize the loss of synapsin I and p38 to a specific population ofhippocampal neurons. However, two lines of evidence support the hypothesis that the cortex were not associated with a concomitant decrease in synreduced amounts of these proteins result primarily from the loss apsin I and ~38, which suggests that changes in the specific of pyramidal cells. First, there was a close correspondence between the time course of pyramidal cell loss and that of the loss of synapsin I and ~38. Second, the greatest number of synapses concentration of a protein high in relative abundance (GFAP) in hippocampal tissue occur between axon collaterals of pyramido not necessarily alter the concentrations of proteins low in dal cells and dendrites of other pyramidal cells (Braitenberg and Schiiz, 1983) ; therefore, the degree (75% decrease) and relative abundance (e.g., synapsin I and ~38). extent (CA l-CA4) of pyramidal cell loss caused by TMT would be expected to result in a considerable loss of synapses and synapse-localized proteins. The degree (60-70%) and extent (CA I-CA4) of the decrease in synapsin I and p38 are consistent with these expectations. It is likely that a more detailed understanding of the cellular targets associated with hippocampal damage due to TMT or other injury-inducing paradigms may be achieved through the use of monoclonal antibodies that preferentially label specific cellular and subcellular elements of the hippocampal formation. Such antibodies have recently been described (Caceres et al., 1984; De Camilli et al., 1984; Levitt, 1984; Moskal and Schaffner, 1986 ).
An increase in the amount of synapsin I and p38 per hippocampus and an increase in the concentration of these proteins in hippocampus were observed between 5 and ,12 weeks after
